A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer
NCT01784913
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
UV1 synthetic peptide vaccine and GM-CSF
Sponsor
Ultimovacs ASA